Studies further demonstrate that SIN reduces apoptosis rates, ROS levels, and MDA expression by activating the Nrf2/ARE signaling pathway, thereby attenuating OS associated with cardiac hypertrophy [294]. Here, NFE2L2 is linked to cardiac hypertrophy.